Modulation of [35S]GTPγS binding to Chinese hamster ovary cell membranes by D(2(short)) dopamine receptors

Neuroscience Letters

Volumn 280, Issue 2, 2000, Pages 135-138

  Terasmaa, Anton ^a,b   Finnman, Ulla Britt ^b   Owman, Christer ^c   Ferré, Sergi ^b   Fuxe, Kjell ^b   Rinken, Ago ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

35S GTP S binding; 3H raclopride binding; D2 subtype; Dopamine receptors; G protein; Ligand potency and efficacy

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOCODEINE; APOMORPHINE; BROMOCRIPTINE; BUTACLAMOL; DIHYDROERGOCRISTINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOCORNINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; PROPYLNORAPOMORPHINE; QUINPIROLE; RACLOPRIDE; DIAGNOSTIC AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; N (4 ISOTHIOCYANATOPHENETHYL)SPIPERONE; N-(4-ISOTHIOCYANATOPHENETHYL)SPIPERONE; SPIPERONE; SULFUR; TRITIUM;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; ANIMAL; BINDING COMPETITION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HAMSTER; MEMBRANE; METABOLISM; PHYSIOLOGY; RADIOASSAY;

ANIMALS; BINDING, COMPETITIVE; BUTACLAMOL; CHO CELLS; CRICETINAE; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; MEMBRANES; RACLOPRIDE; RADIOLIGAND ASSAY; RATS; RECEPTORS, DOPAMINE D2; SPIPERONE; SULFUR RADIOISOTOPES; TRITIUM;

EID: 0033621756     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00776-X     Document Type: Article

References (16)

1. 35S]GTPγS binding: a tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells. Neurochem. Res., 21 (1996) 1301-1307.
2. Birnbaumer, L. and Birnbaumer, M., Signal transduction by G proteins: 1994 edn. J. Rec. Sign. Transd. Res., 15 (1995) 213-252.
3. Chen, C. and Okayama, H., High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7 (1987) 2745-2752.
4. 50) of an enzymatic reaction. Biochem. Pharmacol., 22 (1973) 3099-3108.
5. Cussac, D., Kordon, C., Enjalbert, A. and Saltarelli, D., ADP-ribosylation of Gαi and Gαo in pituitary cells enhances their recognition by antibodies directed against their carboxyl termini. J. Rec. Sign. Transd. Res., 16 (1996) 169-190.
6. 2long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol., 118 (1996) 1544-1550.
7. Hilf, G., Gierschik, P. and Jakobs, K.H., Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiophosphate) to guanine-nucleotidde-binding proteins in cardiac membranes. Eur. J. Biochem., 186 (1989) 725-731.
8. Lazareno, S. and Birdsall, N.J., Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum Schild and Cheng-Prusoff equations. Br. J. Pharmacol., 109 (1993) 1110-1119.
9. Lepiku, M., Rinken, A., Järv, J. and Fuxe, K., Kinetic evidence for isomerization of the dopamine receptor-raclopride complex. Neurochem. Int., 28 (1996) 591-595.
10. Nürnberg, B., Gudermann, T. and Schultz, G., Receptors and G proteins as primary components of transmembrane signal transduction 2. G proteins: structure and function. J. Mol. Med., 73 (1995) 123-132.
11. 1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state. Naunyn-Schmiedeberg's Arch. Pharmacol., 356 (1997) 551-561.
12. 2 dopamine receptor. NeuroReport, 10 (1999) 493-495.
13. 35S]GTPγS binding in rat striatal membranes. Biochem. Pharmacol., 57 (1999) 155-162.
14. Wieland, T. and Jakobs, K.H., Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Meth. Enzymol., 237 (1994) 3-13.
15. 2 dopamine receptors in brain. J. Pharmacol. Exp. Ther., 257 (1991) 608-615.
16. Yang, Q. and Lanier, S.M., Influence of G protein type on agonist efficacy. Mol. Pharmacol., 56 (1999) 651-656.